Skip to content
Credit reportVerdict and grounds
Made on 20-11-2026 at 22:44
Reference CK-0798707205-20261120

Mimedic

ActivePrivate limited company0798.707.205Rue de l'Orgalisse 31, 5354 Ohey
founded in 2023 · one director

Sources: the KBO register on 20-11-2026; the National Bank, 2025 annual accounts filed on 29-06-2026; the Belgian Official Gazette, latest deed of 18-02-2026.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
Gross margin
€99,276
▲ 20.4% against 2024
Net result
€74,059
▲ 19.3% against 2024
Equity
€241,467
▲ 44.2% against 2024
Cash
€190,667
▲ 56.5% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. Mimedic made a profit in every financial year since 2023.Annual accounts 2023 to 2025 page 2
  2. Equity stands at €241,467, or 97.3% of the balance sheet total of €248,132.Annual accounts 2025 page 2
  3. Cash rose from €121,801 to €190,667. Debts due within one year fell from €8,328 to €6,665.Annual accounts 2024 and 2025 page 2
  4. The last three annual accounts came in on time. The 2025 accounts were filed 32 days before the end of the term.National Bank, filing of 29-06-2026 page 4

Representation

The signing rule is in the deed of 23-02-2023.

Articles of association, Belgian Official Gazette of 23-02-2023, deed 23316523

Ownership

holds all 100 shares.

Deed of 23-02-2023

Mimedic · 0798.707.205 · credit report of 20-11-2026Page 1 of 5
Mimedic0798.707.205 · report of 20-11-2026

Financial situation

Annual accounts 2023 to 2025, as filed with the National Bank

Gross margin and net resultin euro

2023132,442202482,424202599,2762023102,356202462,052202574,059
gross marginnet result

Equity and debtsin euro

202320242025241,4676,665
equitydebts

Cashin euro

202367,8592024121,8012025190,667
on the balance sheet date
Financial year202310 months20242025Trend
Results
Gross margin€132,442€82,424€99,276
Operating result€130,856€78,361€95,165
Net result€102,356€62,052€74,059
Balance sheet at the closing date
Equity€105,356€167,408€241,467
Debts€17,034€8,328€6,665
Debts due within one year€17,034€8,328€6,665
Cash€67,859€121,801€190,667
Balance sheet total€122,390€175,735€248,132
Ratios
Solvency86.1%95.3%97.3%
Liquidity6.5720.3336.85

Source: Annual accounts 2025, abbreviated format, filed on 29-06-2026 (2026-00216087); Annual accounts 2024, full format, filed on 20-06-2025 (2025-00165919); Annual accounts 2023, filed on 21-06-2024 (2024-00155753).

The operating result of 2025 is 21% higher than in 2024.

Debts fell by €1,662 in 2025.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

The financial year to 31-12-2023 ran for 10 months.

Mimedic · 0798.707.205 · credit report of 20-11-2026Page 2 of 5
Mimedic0798.707.205 · report of 20-11-2026

Board, signature and ownership

Position on 20-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

The signing rule is in the deed of 23-02-2023.

Articles of association, Belgian Official Gazette of 23-02-2023, deed 23316523

Board

one director in office
Director (not named in the articles)since 20-02-2023
deed of 23-02-2023

Ownership and group

Shareholders

holds all 100 shares.

Deed of 23-02-2023

Mimedic · 0798.707.205 · credit report of 20-11-2026Page 3 of 5
Mimedic0798.707.205 · report of 20-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 32 days before the deadline.

NBB filing

Company renamed from Docteur Urgentiste to Mimedic. Registered office moved within Ohey. The registered office moved from La Bouchaille 229, 5350 Ohey to Rue de l’Orgalisse, 31/3, 5354 Ohey (Jallet).

Gazette, deed 26311668

Equity above €200,000. With a profit in every financial year since 2023, equity grows to €241,467.

Financial

Annual accounts 2024 filed, 41 days before the deadline.

NBB filing

Weakest financial year. The net result drops to €62,052, the lowest from 2023 to 2025. It recovers the following year.

Financial

Liquidity more than triples. The current ratio rises from 6.57 to 20.33. Short-term debt falls from €17,034 to €8,328.

Financial

Equity above €150,000. With a profit in every financial year since 2023, equity grows to €167,408.

Financial

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as Mimedic has now: micro, 2 to 5 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 95.7% were still trading, 2.5% had stopped another way and 1.8% had gone bankrupt.

still trading 95.7% stopped another way 2.5% bankrupt 1.8%

Other findings

Peppol

Reachable for e-invoices since 26-12-2025, under 0208:0798707205.

Sanctions lists

Mimedic · 0798.707.205 · credit report of 20-11-2026Page 4 of 5
Mimedic0798.707.205 · report of 20-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units20-11-2026KBO 0798.707.205
National Bank of BelgiumAnnual accounts 2025, abbreviated format29-06-20262026-00216087
National Bank of BelgiumAnnual accounts 2024, full format20-06-20252025-00165919
National Bank of BelgiumAnnual accounts 2023 to 202321-06-20242024-00155753
Belgian Official GazetteArticles of association with the signing rule23-02-2023deed 23316523
Peppol DirectoryRegistration for e-invoices26-12-20250208:0798707205
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name19-11-2026
CheckedChecked score, bankruptcy probability, credit, comparable companies20-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 20-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

Mimedic · 0798.707.205 · credit report of 20-11-2026Page 5 of 5